The Role of Establishing a Multidisciplinary Team for Idiopathic Granulomatous Mastitis in Improving Patient Outcomes and Spreading Awareness about Recent Disease Trends.
Journal
International journal of breast cancer
ISSN: 2090-3170
Titre abrégé: Int J Breast Cancer
Pays: Egypt
ID NLM: 101568103
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
05
2019
revised:
21
11
2019
accepted:
23
11
2019
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
16
5
2020
Statut:
epublish
Résumé
Iidiopathic granulomatous mastitis (IGM) is stereotypically described as a mysterious entity that mimics breast carcinoma imposing management challenges. In 2002, we established a multidisciplinary team to treat patients with IGM. This study aimed to evaluate the role of this team in improving patient outcomes. Also, a review of literature is provided to highlight recent disease trends. Mean age at diagnosis was 37.9 years ± 6.4. The diagnosis of IGM was confirmed by True-cut biopsy (TCB), Frozen section (FS), and surgical biopsy in 70.5%, 25%, and 4.5% of patients, respectively. FS was used to assess the resection margins in three patients. Suspicion for malignancy was raised in one out of 39 ultrasound reports, and one out of 20 mammography reports. Wide local excision was the main treatment modality (95.5%). 19 patients (43.2%) received corticosteroids. Prior to 2002, IGM was only recognized after surgical resection with a 71% initial false impression of carcinoma. After 2002, the initial false clinical impression of carcinoma dropped to 29.5%. Recurrence rate was 31.82%. Younger age at diagnosis was significantly associated with recurrence ( The establishment of a multidisciplinary team for IGM was associated with a reduced erroneous impression of breast cancer, and a reduced false positive radiological diagnosis of breast carcinoma. FS was a useful confirmatory procedure. Our series included the first case of a diffuse papular rash as a systemic manifestation of IGM. Recent literature indicates that IGM is changing its face. IGM is being reported in all age groups, and even in males. The clinical manifestations have markedly expanded. Diagnosis by TCB has replaced blind surgical excision. More data regarding predictors of recurrence is accumulating.
Sections du résumé
BACKGROUND
BACKGROUND
Iidiopathic granulomatous mastitis (IGM) is stereotypically described as a mysterious entity that mimics breast carcinoma imposing management challenges. In 2002, we established a multidisciplinary team to treat patients with IGM. This study aimed to evaluate the role of this team in improving patient outcomes. Also, a review of literature is provided to highlight recent disease trends.
RESULTS
RESULTS
Mean age at diagnosis was 37.9 years ± 6.4. The diagnosis of IGM was confirmed by True-cut biopsy (TCB), Frozen section (FS), and surgical biopsy in 70.5%, 25%, and 4.5% of patients, respectively. FS was used to assess the resection margins in three patients. Suspicion for malignancy was raised in one out of 39 ultrasound reports, and one out of 20 mammography reports. Wide local excision was the main treatment modality (95.5%). 19 patients (43.2%) received corticosteroids. Prior to 2002, IGM was only recognized after surgical resection with a 71% initial false impression of carcinoma. After 2002, the initial false clinical impression of carcinoma dropped to 29.5%. Recurrence rate was 31.82%. Younger age at diagnosis was significantly associated with recurrence (
CONCLUSION
CONCLUSIONS
The establishment of a multidisciplinary team for IGM was associated with a reduced erroneous impression of breast cancer, and a reduced false positive radiological diagnosis of breast carcinoma. FS was a useful confirmatory procedure. Our series included the first case of a diffuse papular rash as a systemic manifestation of IGM. Recent literature indicates that IGM is changing its face. IGM is being reported in all age groups, and even in males. The clinical manifestations have markedly expanded. Diagnosis by TCB has replaced blind surgical excision. More data regarding predictors of recurrence is accumulating.
Identifiants
pubmed: 32411481
doi: 10.1155/2020/5243958
pmc: PMC7204166
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5243958Informations de copyright
Copyright © 2020 Rami J. Yaghan et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest regarding the publication of this article.
Références
Turk J Med Sci. 2018 Feb 23;48(1):16-23
pubmed: 29479939
ANZ J Surg. 2018 Jun;88(6):635-639
pubmed: 28749045
Saudi Med J. 2004 Nov;25(11):1715-9
pubmed: 15573210
Asian Pac J Cancer Prev. 2019 Mar 26;20(3):929-934
pubmed: 30912417
J Med Ultrason (2001). 2017 Jan;44(1):109-115
pubmed: 27787642
Jpn J Clin Oncol. 1997 Aug;27(4):274-7
pubmed: 9379518
World J Surg. 2017 May;41(5):1313-1321
pubmed: 28050664
Clin Case Rep. 2018 Oct 10;6(11):2208-2210
pubmed: 30455922
J Plast Reconstr Aesthet Surg. 2011 Dec;64(12):1604-7
pubmed: 21813343
Eur J Breast Health. 2018 Apr 01;14(2):112-116
pubmed: 29774320
Breast J. 2013 Jul-Aug;19(4):411-8
pubmed: 23663101
Breastfeed Med. 2017 Sep;12(7):415-421
pubmed: 28731822
Arch Gynecol Obstet. 2011 Nov;284(5):1189-95
pubmed: 21207047
World J Clin Cases. 2014 Dec 16;2(12):852-8
pubmed: 25516860
Insights Imaging. 2016 Aug;7(4):531-9
pubmed: 27221974
J Turk Ger Gynecol Assoc. 2010 Sep 01;11(3):127-30
pubmed: 24591917
Insights Imaging. 2018 Feb;9(1):59-71
pubmed: 29404980
Case Rep Oncol. 2016 Aug 31;9(2):516-519
pubmed: 27721777
Pathology. 2017 Jun;49(4):405-412
pubmed: 28442140
Breast Dis. 2017;37(2):69-72
pubmed: 28655119
Breast Care (Basel). 2012 Aug;7(4):297-301
pubmed: 23904832
Clin Imaging. 2017 May - Jun;43:199-201
pubmed: 28364724
Breast Dis. 2015;35(1):19-24
pubmed: 24989362
Eur J Breast Health. 2018 Nov 05;15(1):32-36
pubmed: 30816358
Arch Pathol Lab Med. 1995 Aug;119(8):680
pubmed: 7646321
Turk J Med Sci. ;47(5):1590-1592
pubmed: 29151337
Eur J Radiol. 2013 Apr;82(4):e165-75
pubmed: 23200627
Breast J. 2014 May-Jun;20(3):258-66
pubmed: 24673796
S Afr Med J. 1977 Jul 2;52(1):14-6
pubmed: 560723
Am J Clin Pathol. 2016 May;145(5):635-45
pubmed: 27247368
J Clin Pathol. 2017 Oct;70(10):827-831
pubmed: 28931582
Breast J. 2004 Jul-Aug;10(4):318-22
pubmed: 15239790
Am J Clin Pathol. 1972 Dec;58(6):642-6
pubmed: 4674439
Electron Physician. 2017 Sep 25;9(9):5375-5379
pubmed: 29038724
J Rheumatol. 2020 Jun 1;47(6):924-927
pubmed: 31203215
Turk J Surg. 2017 Jun 01;33(2):100-103
pubmed: 28740959
Breast J. 2019 Jan;25(1):80-85
pubmed: 30449049
Breast J. 2014 Nov-Dec;20(6):586-91
pubmed: 25228089